LABU - Direxion Daily S&P Biotech Bull 3X Shares
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF is an exchange traded fund launched by Direxion Investments. It is managed by Rafferty Asset Management, LLC. It invests in public equity markets of the United States.
As of Aug 14, 2026: spot at $275.67, ATM IV 82.6%, max pain $215.00, net GEX $627.4K.
- Sector
- Financial Services
- Industry
- Asset Management
- Market Cap
- $1.53B
- Beta
- 3.05
- 52-Week Range
- 65.82-333
- Dividend Yield
- $1.34
- IPO Date
- May 28, 2015
- Exchange
- AMEX
What LABU Looks Like to Options Traders Today
IV rank of 25.2% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); positive net gamma exposure ($627.4K) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (0.083) prices calls richer than puts, often reflecting upside speculation or squeeze risk.
What This Page Covers
The LABU overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure.
Frequently asked LABU overview questions
- What is LABU?
- LABU is the ticker symbol for Direxion Daily S&P Biotech Bull 3X Shares, an listed exchange-traded fund. Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF is an exchange traded fund launched by Direxion Investments. It is managed by Rafferty Asset Management, LLC. Listed on AMEX. LABU is the ETF ticker shown on this page; ETF traders use the fund for diversified exposure to its underlying basket, for sector and factor rotation, and for hedging or replication strategies via the listed options chain.
- What does the LABU options snapshot look like today?
- As of Aug 14, 2026, the LABU options snapshot shows spot at $275.67, ATM IV 82.6%, IV rank 25.2%, max pain $215.00, net GEX $627.4K, expected move 23.69%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are LABU's key statistics?
- Direxion Daily S&P Biotech Bull 3X Shares (LABU) carries a market capitalization of $1.53B, 52-week range of 65.82-333. Full holdings disclosure, expense ratio, and tracking-error history live on the per-ticker fundamentals page or the sponsor's site; daily NAV and premium/discount-to-NAV are accessible from the same view. These structural inputs frame how the ETF options market prices implied volatility relative to its constituents.
- What sector or industry does LABU belong to?
- Direxion Daily S&P Biotech Bull 3X Shares operates in the Financial Services sector, in the Asset Management industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare LABU's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the LABU data on this page?
- The options snapshot above is dated Aug 14, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Fund-level fields (sponsor, expense ratio, holdings concentration where available) refresh from the vendor feed nightly. ETF-specific filings (N-CSR, N-PX, N-CEN) update on the SEC EDGAR cadence. FINRA microstructure data refreshes on the source's cadence; for ETFs the off-exchange volume signal is dominated by authorized-participant creation and redemption rather than directional flow.